本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (5662)
All Articles published online
|
Publishing Process of This Article
|
2019-01-08 (publication date) through 2024-07-07
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 章科清, 江琴, 张海兵. 溃疡性结肠炎患者粪菌移植后胃肠道功能及肠道菌群的影响分析. 世界华人消化杂志 2019; 27(1): 68-72 [DOI: 10.11569/wcjd.v27.i1.68] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v27/i1/68.htm |
| 编号 | Citing Articles |
| 1 |
Jin-Tao Zhang, Nan Zhang, Xue-Tao Dong, Xiao-Ran Wang, Hong-Wen Ma, Yan-Di Liu, Mu-Ran Li. Efficacy and safety of fecal microbiota transplantation for treatment of ulcerative colitis: A post-consensus systematic review and meta-analysis. World Journal of Clinical Cases 2024; 12(21): 4691-4702 doi: 10.12998/wjcc.v12.i21.4691
|
| 2 |
Hai Lan Zhao, Shu Zhen Chen, Hao Ming Xu, You Lian Zhou, Jie He, Hong Li Huang, Jing Xu, Yu Qiang Nie. Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta‐analysis. Journal of Digestive Diseases 2020; 21(10): 534 doi: 10.1111/1751-2980.12933
|
| 3 |
Shuying Li, Yan Yin, Dan Xiao, Yong Zou. Supplemental bifid triple viable capsule treatment improves inflammatory response and T cell frequency in ulcerative colitis patients. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01887-2
|
| 4 |
Xi-Yue Tan, Yu-Jia Xie, Xing-Long Liu, Xin-Yun Li, Bo Jia, Duygu AĞAGÜNDÜZ. A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/8266793
|